RKDA
Arcadia Biosciences, Inc.
$0.69
+0.03 (+4.08%)
At close · Jul 16
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company's ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$1.38M
Shares
2,056,884
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Stanley E. Jacot | CEO | $518,108 |
| Thomas Schaefer | CEO | $499,477 |
| Mark Kawakami | CFO | $370,175 |
| Laura Pitlik | Chief Marketing Officer | $154,826 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Stanley E. Jacot | CEO | $525,177 |
| Thomas Schaefer | CEO | $380,538 |
| Laura Pitlik | Chief Marketing Officer | $346,271 |
| Mark Kawakami | CFO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Stanley E. Jacot | CEO | $749,467 |
| Pamela Haley | CFO | $408,503 |
| Kevin Comcowich | Chair of the Board of Directors | $208,088 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Matthew Plavan | CEO | $1,606,004 |
| Chris Cuvelier | Chief Growth Officer | $535,655 |
| Pamela Haley | CFO | $474,416 |
| Laura Pitlik | Chief Marketing Officer | $343,307 |
| Former Interim Chief | Executive Officer | — |
| Stanley E. Jacot | CEO | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Matthew Plavan | CEO | $794,148 |
| Sarah Reiter | Chief Commercial Officer | $527,155 |
| Pamela Haley | CFO | $443,191 |
| Randall Shultz | CTO | $431,480 |
| Laura Pitlik | Chief Marketing Officer | — |
| Chris Cuvelier | Chief Growth Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Matthew Plavan | CEO | $581,078 |
| Rajendra Ketkar | CEO | $562,428 |
| Sarah Reiter | Chief Commercial Officer | $456,392 |
| Randall Shultz | CTO | $339,564 |
| Pamela Haley | CFO | $285,035 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Rajendra Ketkar | CEO | $904,484 |
| Sarah Reiter | Chief Commercial Officer | $782,740 |
| Matthew Plavan | CEO | $583,010 |
| Pamela Haley | CFO | $233,894 |